GSK has already been cutting the price of its brand to try to minimise the impact ... “We expect the recently approved generic Advair to have minimal impact on this highly differentiated ...
Analysts now expect generic Advair to be delayed until mid-2018 ... In Europe, there are approved generics, although under the brand name Seretide the drug still produces significant sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results